Healthline

Side Effects of Breo Ellipta: What You Need to Know

If you have a certain kind of lung condition, your doctor might suggest Breo Ellipta as a treatment option for you. Breo Ellipta is a prescription drug used to treat chronic obstructive pulmonary ...
FiercePharma

BREO® ELLIPTA™ now available in the U.S. for the treatment of COPD

RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., Oct. 30, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that BREO ELLIPTA, a ...
Healthline

Dosage Details for Breo Ellipta (Fluticasone Furoate/Vilanterol)

The prescribed dosage for Breo Ellipta may depend on your individual treatment plan. Factors like your condition, medical history, age, and other treatments you take may affect your dosage of Breo ...
FiercePharma

FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US

GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO ® ELLIPTA ® (fluticasone furoate/vilanterol [FF/VI]) ...
Business Wire

Global BREO Ellipta Drugs Market to Witness Rapid Growth by 2031, Fueled by Growing Chronic Obstructive Pulmonary Disease (COPD) Drugs Market - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global BREO Ellipta Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global BREO ellipta drugs market is driven ...